1. Diagnostic Delay in Adolescents with Cancer During COVID-19 Pandemic: A New Price for Our Patients to Pay
- Author
-
Andrea Pession, Paola Quarello, Marco Zecca, Maurizio Mascarin, Franca Fagioli, Marina Bertolotti, Teresa Perillo, Giuseppe Milano, Milena Maule, Assunta Tornesello, Andrea C. Ferrari, Marta Pierobon, Marco Spinelli, Quarello, Paola, Ferrari, Andrea, Mascarin, Maurizio, Milano, Giuseppe M, Tornesello, Assunta, Bertolotti, Marina, Spinelli, Marco, Pierobon, Marta, Perillo, Teresa, Maule, Milena, Zecca, Marco, Pession, Andrea, and Fagioli, Franca
- Subjects
Pediatrics ,medicine.medical_specialty ,Delayed Diagnosis ,Adolescent ,Referral ,Coronavirus disease 2019 (COVID-19) ,COVID-19 ,diagnostic delay ,solid tumor ,Disease ,Neoplasms ,Pandemic ,medicine ,Pediatric oncology ,Humans ,Young adult ,Medical diagnosis ,Child ,Pandemics ,Retrospective Studies ,business.industry ,Cancer ,medicine.disease ,Oncology ,Communicable Disease Control ,Pediatrics, Perinatology and Child Health ,business - Abstract
Worldwide, the coronavirus 19 disease pandemic caused a worse chance of a timely diagnosis for cancer patients. We conducted a retrospective analysis of new diagnoses registered in the national pediatric oncology database, comparing the first lockdown period (March-May 2020) with the same period of 2015-2019. The total number of cases (0-19 years) dropped by 20.8% (from 441 between 2015 and 2019 to 349 in 2020). A major reduction was observed for adolescents (15-19 years) (-32.9%) and for adolescents with solid tumors (-56.4%, p = 0.03). Our data suggest that the enforced lockdown reduced the possibility for these already vulnerable patients to access the referral centers.
- Published
- 2022
- Full Text
- View/download PDF